Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level

Endocrinology

Volumn 140, Issue 10, 1999, Pages 4732-4738

  Teixeira, J ^a   Fynn Thompson, E ^a   Payne, A H ^a   Donahoe, P K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE; ANDROGEN; GLYCOPROTEIN; GROWTH INHIBITOR; ISOPROTEIN; MULLERIAN INHIBITING HORMONE; MULLERIAN INHIBITING SUBSTANCE RECEPTOR; MULLERIAN-INHIBITING HORMONE; MULLERIAN-INHIBITING SUBSTANCE RECEPTOR; RECEPTOR; RECOMBINANT PROTEIN; STEROID; STEROID 17ALPHA MONOOXYGENASE; TESTIS PEPTIDE HORMONE;

ANDROGEN SYNTHESIS; ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HOMEOSTASIS; LEYDIG CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; METABOLISM; PHYSIOLOGY;

ANDROGENS; ANIMALS; GENE EXPRESSION; GLYCOPROTEINS; GROWTH INHIBITORS; HUMANS; LEYDIG CELLS; MALE; PROTEIN ISOFORMS; RATS; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS; STEROID 17-ALPHA-HYDROXYLASE; STEROIDS; TESTICULAR HORMONES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 85047678455     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.10.7075     Document Type: Article

References (47)

1. Dax1 antagonizes Sry action in mammalian sex determination
2. Antimullerian hormone: The Jost factor
3. Recherches sur la differenciation sexuelle de l'embryon de lapin
4. Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells
5. Molecular biology of MIS and its receptors
6. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro
7. Immunopurified anti-mullerian hormone does not inhibit spontaneous resumption of meiosis in vitro of rat oocytes
8. Mullerian inhibiting substance as oocyte meiosis inhibitor
9. The inhibitory effects of mullerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells
10. Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid Mullerian-inhibiting substance and androgen content
11. Abnormal sexual development in transgenic mice chronically expressing Mullerian inhibiting substance
12. Ontogeny of reproductive abnormalities induced by deregulation of anti-Mullerian hormone expression in transgenic mice
13. Mullerian-inhibiting substance function during mammalian sexual development
14. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation
15. Regulation of expression of steroidogenic enzymes in Leydig cells
16. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature
17. Receptors for anti-mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation
18. Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats
19. SMADs: Mediators and regulators of TGF-beta signaling
20. Cloning and expression of cDNA for anti-mullerian hormone
21. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Mullerian duct
22. Cloning, expression and alternative splicing of the receptor for anti-Mullerian hormone
23. Developmental expression Of a candidate mullerian inhibiting substance type II receptor
24. Mullerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells
25. Human Mullerian inhibiting substance: Enhanced purification imparts biochemical stability and restores antiproliferative effects
26. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
27. A graded organ culture assay for the detection of Mullerian inhibiting substance
28. Hormonal regulation of steroidogenic enzyme gene expression in Leydig cells
29. Characterization of several clonal lines of cultured Leydig tumor cells: Gonadotropin receptors and steroidogenic responses
30. Bioassay, purification, cloning, and expression of Mullerian inhibiting substance
31. Mullerian duct regression and antiproliferative bioactivities of Mullerian inhibiting substance reside in its carboxyterminal domain
32. Androgens
33. Anti-mullerian hormone in early human development
34. Mullerian inhibiting substance (MIS) in humans: Normal levels from infancy to adulthood
35. Anti-Mullerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development
36. Fetal development of Leydig cell activity in the mouse is independent of pituitary gonadotroph function
37. Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice
38. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development
39. Leydig cells: Endocrine, paracrine, and autocrine regulation
40. c-myc mRNA is down-regulated during myogenic differentiation by accelerated decay that depends on translation of regulatory coding elements
41. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone
42. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syn-drome and Albright hereditary osteodystrophy
43. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone
44. Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome